Though our study did not explore the role that LAIR2 may have in checkpoint blockade immunotherapies, several studies have highlighted a predictive role for tumor-infiltrating Treg cells in response to PD-1/PD-L1 blockade. This evidence concerns the gene LAIR2 and neoplasm.